Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
TRVI

Trevi Therapeutics (TRVI) stock: insider trades, news & valuation

Net selling
Close · Oct 9, 2026 $13.19 +2.8% on the day +33.0% over 12 months 52-week range $9.71 – $19.50

Share price and insider trades

TRVI closeInsider buyInsider sale
5101520NovDecJan 2026FebMarAprMayJunJulAugSepOctSold $595,806 on 2026-09-15 · Michael Thomas Heffernan
Bought, 12 months$0
Sold, 12 months$596K
Insiders buying0
Insiders selling1

Trevi Therapeutics insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 1 sold $596K of TRVI stock on the open market.

TRVI insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q3 2026: $596K sold (4 trades)Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026—0$596K4

Valuation, profit and volume

P/E (trailing)n/aSector median —
Market value— 
Profit margin—Revenue growth —
Volume vs. 50-day2.9×Last 5 sessions
Insiders' paper profit—On all tracked purchases —

Summary

Over the past 12 months, 0 Trevi Therapeutics, Inc. insiders reported open-market purchases totaling $0, while 1 insider reported sales totaling $596K. 4 of 4 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Sep 17SEC Michael Thomas HeffernanDirector Sell Plan 20,9526,451 held (−76%) $15.09 $316K -12.6% —
Sep 17SEC Michael Thomas HeffernanDirector Sell Plan 18,3216,451 held (−74%) $15.09 $276K -12.6% —
Sep 17SEC Michael Thomas HeffernanDirector Sell Plan 1006,351 held (−2%) $15.88 $2K -16.9% —
Sep 17SEC Michael Thomas HeffernanDirector Sell Plan 1006,351 held (−2%) $15.88 $2K -16.9% —

Insiders at Trevi Therapeutics, Inc.

InsiderBoughtSoldLast filingScore
Michael Thomas HeffernanDirector — $596K Sep 17, 2026 —

TRVI stock: common questions

Are Trevi Therapeutics, Inc. insiders buying TRVI stock?

In the past 12 months, 0 insiders reported open-market purchases of TRVI worth $0.

Are Trevi Therapeutics, Inc. insiders selling TRVI stock?

1 insiders reported sales worth $596K over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is TRVI's 52-week range?

Over the past year TRVI has traded between $9.71 and $19.50. It last closed at $13.19 on Oct 9, 2026.